Media Newsroom of

Alpha Cognition, Inc.

Follow on Social Network

AlphaCognition, Inc. is a privately held biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord, such as ALS and Alzheimer's disease.

Alpha Cognition Receives Japanese Patent for Alzheimer's Disease Drug Alpha-1062, Further Strengthening Patent Portfolio

Alpha Cognition Receives Japanese Patent for Alzheimer's Disease Drug Alpha-1062, Further Strengthening Patent Portfolio

Alpha Cognition, Inc. (“ACI”), a biotherapeutics drug developer with near term commercialization potential for its Alpha-1062 Alzheimer’s drug, is pleased to announce an additional patent was recently granted in Japan for the treatment of neurodegenerative diseases, further demonstrating the value…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login